Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)

This is a meeting report of the 3rd Translational Hepatology Meeting held in Alicante, Spain, in October 2021. The meeting, which was organized by the Spanish Association for the Study of the Liver (AEEH), provided an update on the recent advances in the field of basic and translational hepatology,...

Descripción completa

Detalles Bibliográficos
Autores: Gallego Durán, Rocío, Albillos, Agustín, Ampuero Herrojo, Javier, Arechederra, María, Bañares, Rafael, Blas-García, Ana, Gracia Sancho, Jordi
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:España
Institución:Universidad de Sevilla (US)
Repositorio:idUS. Depósito de Investigación de la Universidad de Sevilla
OAI Identifier:oai:idus.us.es:11441/139450
Acceso en línea:https://hdl.handle.net/11441/139450
https://doi.org/10.1016/j.gastrohep.2022.02.005
Access Level:acceso abierto
Palabra clave:MAFLD
MASH
Steatohepatitis
Fibrosis
Hepatocellular carcinoma
Esteatosis
Esteatohepatitis
Carcinoma hepatocelular
Descripción
Sumario:This is a meeting report of the 3rd Translational Hepatology Meeting held in Alicante, Spain, in October 2021. The meeting, which was organized by the Spanish Association for the Study of the Liver (AEEH), provided an update on the recent advances in the field of basic and translational hepatology, with a particular focus on the molecular and cellular mechanisms and therapeutic targets involved in metabolic-associated fatty liver disease (MAFLD), metabolic- associated steatohepatitis (MASH), cirrhosis and end-stage hepatocellular carcinoma (HCC).